Gene: AIG1
Official Full Name: androgen induced 1provided by HGNC
Gene Summary: Enables hydrolase activity. Involved in long-chain fatty acid catabolic process. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22583 | AIG1 Knockout cell line (HeLa) | Human | AIG1 | 1:3~1:6 | Negative | Online Inquiry |
KO22584 | AIG1 Knockout cell line (HCT 116) | Human | AIG1 | 1:2~1:4 | Negative | Online Inquiry |
KO22585 | AIG1 Knockout cell line (HEK293) | Human | AIG1 | 1:3~1:6 | Negative | Online Inquiry |
KO22586 | AIG1 Knockout cell line (A549) | Human | AIG1 | 1:3~1:4 | Negative | Online Inquiry |
AIG1 Gene Knockout Cell Lines are advanced genetically engineered models specifically designed to elucidate the functional roles of the AIG1 gene in various biological processes. These cell lines feature a targeted knockout of the AIG1 gene, which is implicated in cellular signaling pathways associated with immune responses and inflammation. By disrupting the gene's expression, researchers can investigate the phenotypic changes and signaling alterations that arise, offering valuable insights into the gene's contribution to health and disease.
The key mechanism behind AIG1 Gene Knockout Cell Lines involves the use of CRISPR-Cas9 technology, which allows precise editing of the genome to achieve the knockout of the AIG1 locus. This method not only ensures a complete ablation of gene function but also provides a platform for studying compensatory mechanisms or off-target effects that may arise due to the genetic modification. As such, these cell lines are invaluable tools for researchers aimed at understanding the complexities of cellular biology, immunology, and potential therapeutic targets.
Scientifically, the significance of AIG1 Gene Knockout Cell Lines extends to various applications in both research and clinical settings. They serve as pivotal models for investigating autoimmune diseases, inflammatory disorders, and cancer biology, facilitating the development of novel therapeutic interventions. Their utility in drug discovery and testing is noteworthy, as researchers can assess the efficacy and safety of potential treatments in a controlled environment reflective of human disease states.
What sets AIG1 Gene Knockout Cell Lines apart from alternative models is their state-of-the-art genetic modification, coupled with high reproducibility and reliability in experimental outcomes. While traditional cell lines may have inherent variability and limitations in accurately mimicking human disease mechanisms, AIG1 knockout models offer a level of precision and specificity that enhances the validity of research findings.
For researchers and clinicians, the value of utilizing AIG1 Gene Knockout Cell Lines lies in their ability to contribute to a deeper understanding of disease mechanisms and improve translational research outcomes. By choosing our product, users are not only equipping themselves with a powerful experimental tool but are also engaging with a company known for its expertise in genetic engineering and a commitment to advancing the frontiers of biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.